A Comparison of Acute Lymphoblastic Leukemia in Down Syndrome and Non— Down Syndrome Children: The Role of Trisomy 21

Abstract

Down syndrome (DS), which occurs once in every 800 births, is associated with a trisomy on locus 21. Among the many aberrations caused by DS, including shortened stature and distorted facies, are several blood dyscrasias, including childhood leukemias—namely, acute myeloid leukemia (AML) and acute lymphoblastic, or lymphocytic, leukemia (ALL). One focus of the diagnosis of ALL is to distinguish it from AML.The benefits of immunophenotyping extend to treatment as well. ALL is associated with an inherited trisomy 21 in DS children (ALL-DS) and with acquired trisomies, +21, 8, and 13, in non-DS children (ALL-NDS). The differences in treatment, outcome, and prognosis between ALL-DS and ALL-NDS can be attributed to the interaction of their respective trisomies with several genetic mutations, including one on the GATA1 growth factor transcription gene. Other mutations are the gene fusion at TEL/AML1, and a new mutation found, which labels the Janus Kinase gene or JAK2 as on oncogenic precursor, which when associated with the B-cell precursor gene or BCP is highly leukomogenic. The treatments for the 2 groups have been based on quality of risk, with ALL-DS children having the highest risk along with the poorest prognosis, but alterations in medication regimens have brought treatment outcomes to near equality. It is worthwhile to study the trisomy 21 because in the future it may provide an understanding of all blood dyscrasias.

Keywords

down syndrome trisomy 21 ALL

Get full access to this article

View all access options for this article.

References

Arico, M. , Ziino, O. , Valsecchi, M.G. , & Cazzaniga, C.B. (2008). Acute lymphoblastic leukemia and Down syndrome. Cancer, 113, 515-521.

Arya, L.S. ( 2004). Acute lymphoblastic leukemia: Current therapy. Indian Journal of Medical and Pediatric Oncology, 25, 11-17.

Bercovich, D. , Ganmore, I. , Scott, L.M. , Wainrib, G. , Birger, Y. , Elimelich, A. , et al. (2008). Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down syndrome. Lancet, 372, 1484-1492.

Chen, H. ( 2007). Down syndrome. Retrieved November 14, 2008, from http://www.emedicine.com/ped/TOPIC615.HTM

Chessells, J.M. , Harrison, G. , Richards, S.M. , Bailey, C.C. , Hill, F.G.H. , Gibson, B.E. , et al. (2001). Down’s syndrome and acute lymphoblastic leukaemia: Clinical features and response to treatment. Archives of Disease in Childhood, 81, 321-325.

Dixon, N. , Kishnani, P.N. , & Zimmerman, S. ( 2006). Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 142, 149-157.

Fuerst, M. ( 2008). Activating mutations in JAK2 collaborate in Down syndrome ALL. Oncology Times, 30, 57-58.

Hargrave, D.R. , Hann, I.I. , Richards, S.M. , Lilleyman, J.S. , Kinsey, S. , Bailey, C.C. , et al. (2001). Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukemia deaths from 1980 to 1987 (UKALL VIII, X and XI). British Journal of Haematology, 112, 293-299.

Izraeli, S. , Rainis, L. , Herzberg, L. , Smooha, G. , & Birger, Y. ( 2008). Trisomy of 21 in leukomogenesis. Blood Cells, Molecules and Disease, 39, 156-159.

10.

Kuchinskaya, E. ( 2007). Genetic studies of acute lymphoblastic leukemia. Unpublished doctoral dissertation, Karolinska Institutet, Stockholm, Sweden.

11.

Ma, S.K. , Wan, T.S.K. , Cheuk, A.T.C. , Fung, L.F. , Chan, G.C.F. , Chan, S.Y. , et al. (2001). Characteristics of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: A molecular cytogenics study. Leukemia, 15, 1442-1447.

12.

Malinge, S. , Ben-Abdelali, R. , Settegrana, C. , Radford-Weiss, I. , Debre, M. , Beldjord, K. , et al. (2007). Novel activating mutation in a patient with Down syndrome and B cell precursor acute lymphoblastic leukemia. Blood, 109, 2202-2204.

13.

PDQ. National Cancer Institute’s (NCI’s) comprehensive cancer information database. Leukemia, acute lymphoblastic, adult: Treatment. (2008) Patient Information, National Cancer Institute, Retrieved June 23, 2009 from http://www.everettclinic.com/kbase/nci/ncicdr0000257989.htm.

14.

Ozyurek, H. , Turker, H. , Akbalik, M. , Bayrak, A.O. , Ince, H. , & Duru, F. ( 2007). Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy. Pediatric Hematologic Oncology, 24, 447-452.

15.

Steiner, M. , Attarbaschi, A. , Konig, M. , Gadner, H. , Haas, O. , & Mann, G. ( 2004). Equal frequency of TEL/AMI1 acute lymphoblastic leukemia in children with and without Down syndrome. Pediatric Hematology and Oncology, 22, 11-16.

16.

Tsuzuki, S. , Karnan, S. , Horibe, K. , Matsumoto, K. , Kato, K. , Inukai, T. , et al. (2007). Genetic abnormalities in t(21) TEL/ AML1 acute lymphoblastic leukemia: Analysis by means of array-based comparative genomic hybridization. Cancer, 98, 699-706.

17.

Tzortzatou-Stathapoulou, F. , Papadopoulou, A.L. , Moschovi, M. , Botsanis, A. , & Tsangaris, G.T. (2001). Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy. Pediatric Hematologic Oncology, 23, 591-597.

18.

Webb, D. , Roberts, I. , & Vyas, P. ( 2007). Haematology of Down syndrome. Archives of Diseases in Childhood-Fetal and Neonatal Edition, 92, F503-F507.

19.

Whitlock, J. ( 2006). Down syndrome and acute lymphoblastic leukemia. British Journal of Haematology, 135(5), 595-602.

20.

Whitlock, J.A. , Sather, H.N. , Gaynon, P. , Robison, L. , Wells, R.J. , Michael, H. , et al. (2005). Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: A children’s Cancer Group study. Blood, 106, 4043-4049.

21.

Woo, H.Y. , Kim, D.W. , Park, H. , Seong, K.W. , Koo, H.H. , & Kim, S.H. ( 2005). Molecular cytogenic arrangements of gene rearrangements in childhood acute lymphoblastic leukemia. Journal of Korean Medicine and Science, 20, 36-41.

22.

Zeller, B. , Gustafsson, G. , Forestier, E. , Abrahamsson, J. , Clausen, N. , Heldrup, J. , et al. (2005). Acute leukaemia in children with Down syndrome: A population-based Nordic study. British Journal of Haematology , 128, 797-804.